Premium
Predicted number of peanut‐allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Author(s) -
Remington Benjamin C.,
Koppelman Stef J.,
Green Todd D.,
Lack Gideon,
Roberts Graham,
Campbell Dianne E.
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14973
Subject(s) - peanut allergy , medicine , food allergy , population , number needed to treat , allergy , placebo , relative risk , confidence interval , immunology , environmental health , alternative medicine , pathology